VCU Medical Center first in Virginia to implant telescope for macular degeneration

VCU Medical Center first in Virginia to implant telescope for macular degeneration
Smaller than a pea, the telescope implant uses wide-angle micro-optics to improve vision for patients with End-Stage AMD, the most advanced form of macular degeneration. Credit: The Implantable Miniature Telescope (By Dr. Isaac Lipshitz) is a product of VisionCare Ophthalmic Technologies, Inc.

Physicians at the Virginia Commonwealth University Medical Center have become the first in Virginia to successfully implant a telescope in a patient's eye to treat macular degeneration.

The telescope implant is designed to correct end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans. Patients with end-stage AMD have a central blind spot. This vision loss makes it difficult or impossible to see faces, to read and to perform everyday activities such as , preparing meals and self-care.

William H. Benson, M.D., a cornea specialist and chairman of the Department of Ophthalmology at the VCU School of Medicine, performed the procedure.

"We are excited to provide this new surgical option to our advanced macular degeneration patients, who up until now have had limited options for improving vision," Benson said. "Advanced is a devastating disease, which cannot be treated by any available drugs or surgical procedures. The telescope implant offers a new hope for patients with limited vision."

Implantable telescope technology reduces the impact of the central vision blind spot due to end-stage AMD. The telescope implant projects the objects the patient is looking at onto the healthy area of the light-sensing retina not degenerated by the disease. Credit: The Implantable Miniature Telescope (By Dr. Isaac Lipshitz) is a product of VisionCare Ophthalmic Technologies, Inc.

Smaller than a pea, the telescope implant uses micro- to magnify images that would normally be seen in one's "straight ahead" or central vision. The images are projected onto the healthy portion of the retina not affected by the disease, making it possible for patients to see or discern the object of interest.

The (By Dr. Isaac Lipshitz) is a product of VisionCare Ophthalmic Technologies, Inc.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Simple test could detect serious eye condition early

10 hours ago

A simple colour test that could detect the early onset of a condition which accounts for over half of visual impairment certifications in the UK is being researched by scientists at Aston University.

Yellow pigment in eye may aid vision through haze

Aug 25, 2014

Individuals with greater amounts of yellow pigment in the eye may be better able to see distant objects in hazy conditions, suggests a study in the September issue of Optometry and Vision Science, official journal of the A ...

New DNA test for diagnosing diseases linked to childhood blindness

Aug 21, 2014

Researchers in the United Kingdom have demonstrated that advanced DNA testing for congenital cataracts can quickly and accurately diagnose a number of rare diseases marked by childhood blindness, according to a study published online today in Ophthalmology, the journal of the American Academy o ...

User comments